Michael J. Fossler

Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction

John J. Lepore, Eric J. Olson, Laura A. Demopoulos et al. · JACC Heart Failure · 2016 · 164 citations

Cardiac Metabolism, Heart Failure, Chronic Heart Failure +13

The effects of 4‐aminopyridine in multiple sclerosis patients

C. T. Bever, Douglas Young, Paul A. Anderson et al. · Neurology · 1994 · 154 citations

Neurological Disorder, Pharmacotherapy, Translational Medicine +17

A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty

Neil Singla, Harold S. Minkowitz, David G. Soergel et al. · Journal of Pain Research · 2017 · 143 citations · Full text

Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults

Divya Menon-Andersen, John Mondick, Bhuvana Jayaraman et al. · Cancer Chemotherapy and Pharmacology · 2008 · 76 citations

Young Adults, Medicine, Population Pharmacokinetics +2

Hospitalized Patients With and Without Hemodialysis Have Markedly Different Vancomycin Pharmacokinetics: A Population Pharmacokinetic Model-Based Analysis

Vineet Goti, Ayyappa Chaturvedula, Michael J. Fossler et al. · Therapeutic Drug Monitoring · 2018 · 73 citations